Incidence of Interstitial Lung Diseases in the South of Spain 1998-2000: the RENIA Study

Overview

Journal Eur J Epidemiol

Specialty Public Health

Date 2004 Apr 13

PMID 15074571

Citations 20

Authors

Jose Luis Lopez-Campos

Eulogio Rodriguez-Becerra

Affiliations

Soon will be listed here.

Abstract

Unlabelled: This study aims to describe the distribution of interstitial lung diseases (ILD) in the South of Spain.

Methods: A prospective multicentre population-based registry was established in nine provinces in the south of Spain with a population of 6,848,243 during a 3-year period (1998-2000). The number of participant physicians was 36 among 29 public hospitals. The number of diagnoses recorded was 66, divided in eight categories and coded according to ICD-9. A consensus document was elaborated for the classification of diseases and their diagnostic criteria. The number of cases declared was analysed each 3 months and communicated to each one of the participants.

Results: There were 744 cases of them registered with an annual incidence of 3.62 cases/ 100,000. 40.1% of diagnoses were biopsy confirmed. Men had a slightly higher incidence (4.18 cases/ 100,000/year) than women (3.07 cases/100,000/year). The most frequent diseases found were: idiopathic interstitial pneumonias (38.58%), ILD associated to systemic diseases (20.97%), and Sarcoidosis (11.69%). According to province distribution, most of the cases were grouped in an area between the provinces of Seville and Cordoba, which comprised more than 50% of cases.

Conclusions: The study of the incidence of ILD depicts an intermediate situation from previous studies on the incidence and distribution of this group of diseases.

Citing Articles

Interstitial Lung Disease Epidemiology in the Past Three Decades: A Narrative Review.

Puppo F, Carbone R J Clin Med. 2024; 13(23).

PMID: 39685810 PMC: 11641969. DOI: 10.3390/jcm13237350.

Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study.

Ye Y, Sing C, Hubbard R, Lam D, Li H, Hoi-Yee Li G Lancet Reg Health West Pac. 2024; 42:100871.

PMID: 38357389 PMC: 10865042. DOI: 10.1016/j.lanwpc.2023.100871.

Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.

Mendes R, Castello-Simoes V, Trimer R, Garcia-Araujo A, da Silva A, Dixit S Front Rehabil Sci. 2022; 2:744102.

PMID: 36188788 PMC: 9397914. DOI: 10.3389/fresc.2021.744102.

Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.

Dhooria S, Sehgal I, Agarwal R, Muthu V, Prasad K, Kathirvel S PLoS One. 2022; 17(7):e0271665.

PMID: 35862355 PMC: 9302724. DOI: 10.1371/journal.pone.0271665.

Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001-2017.

Salciccioli J, Marshall D, Goodall R, Crowley C, Shalhoub J, Patel P ERJ Open Res. 2022; 8(3).

PMID: 35821757 PMC: 9271755. DOI: 10.1183/23120541.00058-2022.

References

Fink J . Hypersensitivity pneumonitis. Clin Chest Med. 1992; 13(2):303-9. View

Katzenstein A, Myers J . Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998; 157(4 Pt 1):1301-15. DOI: 10.1164/ajrccm.157.4.9707039. View

. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997; 277(11):925-6. View

Lopez-Campos Bodineau J, Guerra J, Lara Blanquer A, Perea-Milla Lopez E, Moreno L, Cebrian Gallardo J . [Analysis of admissions for chronic obstructive pulmonary disease in Andalusia in 2000]. Arch Bronconeumol. 2002; 38(10):473-8. DOI: 10.1016/s0300-2896(02)75268-x. View

. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View

Epler G . Bronchiolitis obliterans organizing pneumonia: definition and clinical features. Chest. 1992; 102(1 Suppl):2S-6S. DOI: 10.1378/chest.102.1_supplement.2s. View

Lapp N, Parker J . Coal workers' pneumoconiosis. Clin Chest Med. 1992; 13(2):243-52. View

Foucher P, Biour M, Blayac J, Godard P, Sgro C, Kuhn M . Drugs that may injure the respiratory system. Eur Respir J. 1997; 10(2):265-79. DOI: 10.1183/09031936.97.10020265. View

. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by.... Am J Respir Crit Care Med. 1999; 160(2):736-55. DOI: 10.1164/ajrccm.160.2.ats4-99. View

10.

Coultas D, Zumwalt R, Black W, Sobonya R . The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994; 150(4):967-72. DOI: 10.1164/ajrccm.150.4.7921471. View

11.

Crystal R, Gadek J, Ferrans V, Fulmer J, Line B, Hunninghake G . Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981; 70(3):542-68. DOI: 10.1016/0002-9343(81)90577-5. View

12.

Roelandt M, Demedts M, Callebaut W, Coolen D, Slabbynck H, Bockaert J . Epidemiology of interstitial lung disease (ILD) in flanders: registration by pneumologists in 1992-1994. Working group on ILD, VRGT. Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding. Acta Clin Belg. 1995; 50(5):260-8. DOI: 10.1080/17843286.1995.11718459. View

13.

Thomeer M, Costabe U, Rizzato G, Poletti V, Demedts M . Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J Suppl. 2002; 32:114s-118s. View

14.

GAENSLER E, CARRINGTON C . Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980; 30(5):411-26. DOI: 10.1016/s0003-4975(10)61291-x. View

15.

Graham W . Silicosis. Clin Chest Med. 1992; 13(2):253-67. View

16.

Vassallo R, Ryu J, Colby T, Hartman T, Limper A . Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000; 342(26):1969-78. DOI: 10.1056/NEJM200006293422607. View

17.

Demedts M, Wells A, Anto J, Costabel U, Hubbard R, Cullinan P . Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl. 2002; 32:2s-16s. View

18.

Schweisfurth H . [Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results]. Pneumologie. 1996; 50(12):899-901. View